Duova Rotacaps
Generic: Tiotropium Bromide/Formoterolby Cipla Limited

Select pack size
Similar medicines
View allAbout Duova Rotacaps
Duova Rotacaps are dry powder capsules made in India by Cipla for use with a Rotahaler inhaler device. Each capsule (Rotacap) contains tiotropium 18 mcg, a long-acting antimuscarinic bronchodilator (LAMA), and formoterol 12 mcg, a long-acting beta2 agonist bronchodilator (LABA). It is a daily maintenance treatment for chronic obstructive pulmonary disease (COPD). Our pack selector counts containers: the carton and container in our product photo each say 30 capsules. We sell 1, 2 and 3 containers, from $0.80 a capsule in the 3 pack, before shipping.
Five points first. No inhaler or capsule that combines tiotropium with formoterol is approved in the US or Canada, we found none on the UK medicines compendium, and we could not find one registered in Australia; each medicine is licensed there only on its own or in other pairings. Duova Rotacaps are for COPD only: they contain no inhaled steroid, and the US formoterol label says a LABA without an inhaled corticosteroid is contraindicated in asthma. They are not a reliever for sudden breathlessness. The single-ingredient labels disagree on timing (tiotropium once a day, formoterol twice a day), so your doctor needs to set how often you use them. And the capsules are for inhalation only: never swallow one. Clinical figures on this page come from the US and UK labels for tiotropium and formoterol and the US Stiolto Respimat label for the LAMA plus LABA class, listed at the end.
Duova Rotacaps at a glance
| Active ingredients | Tiotropium 18 mcg and formoterol 12 mcg per capsule (India's approval record and PharmEasy list tiotropium bromide 18 mcg; Apollo lists tiotropium 18 mcg) |
| Brand and maker | Duova Rotacaps, by Cipla Limited, India (PharmEasy names the Malpur, Solan site) |
| Form and device | Dry powder hard capsule for inhalation. The container in our product photo says "For use with rotahaler" |
| Used for | Maintenance treatment of COPD. Not for asthma and not a reliever |
| Regulatory status | Not approved by the FDA or Health Canada, and not listed on the UK emc; we could not find a TGA registration. No tiotropium with formoterol product is licensed in these countries as far as we can find. India's drug controller (DCG(I)) approved tiotropium bromide 18 mcg with formoterol 12 mcg Rotacaps for COPD on 22 April 2004 |
| Usual dose | Set by your doctor. The Apollo listing says twice a day. Tiotropium labels say one 18 mcg capsule once daily; formoterol labels say twice daily (see below) |
| Half-life | Tiotropium half-life about 25 hours in people with COPD after once daily inhalation of 5 mcg (US Spiriva HandiHaler label 12.3); formoterol works for about 12 hours (UK formoterol label) |
| Packs | 1, 2 and 3 containers of 30 capsules (30, 60 and 90 capsules) |
| Price per capsule | $0.87 (1 container) down to $0.80 (3 pack), before shipping |
| Delivery | 7 to 14 business days to the US, UK, Australia and Canada; $25 shipping under $149, free from $149 |
Price per capsule
Prices below are as of October 2026; the pack selector shows the current price.
| Pack | Capsules | Price | Per capsule | Shipping | Per capsule with shipping |
|---|---|---|---|---|---|
| 1 container | 30 | $26 | $0.87 | $25 | $1.70 |
| 2 containers | 60 | $50 | $0.83 | $25 | $1.25 |
| 3 containers | 90 | $72 | $0.80 | $25 | $1.08 |
All three packs are under the $149 free shipping line, so each single order carries $25 shipping. The larger packs are cheaper per capsule before shipping too. If you also need a Rotahaler, it is a separate item in our shop.
How long a container lasts. This is our arithmetic, not a label figure. A container of 30 capsules lasts 30 days at one capsule once a day, or 15 days at one capsule twice a day. So the 3 pack covers about 3 months at once a day, or about 6 weeks at twice a day. Check that the expiry date on each container covers the weeks you need before you buy a larger pack.
Regulatory status outside India
Duova pairs two medicines that are each licensed on their own in the US, the UK and Canada, but we found the pair itself licensed in none of them. We checked the FDA's drug approvals database (openFDA), the UK electronic medicines compendium (emc) and Health Canada's Drug Product Database on 21 October 2026 and found no product that contains both tiotropium and formoterol. The emc is not the full MHRA register, and we could not search Australia's register (the ARTG) directly, so treat the UK and Australian findings as "none found". The LAMA plus LABA inhalers that are licensed use other pairings:
- Tiotropium with olodaterol: Stiolto Respimat (US), Spiolto Respimat (UK and Australia), Inspiolto Respimat (Canada).
- Glycopyrronium (glycopyrrolate) with formoterol: Bevespi Aerosphere (US and UK).
- Aclidinium with formoterol: Duaklir Genuair (UK and Canada). The US Duaklir Pressair is listed by the FDA as discontinued.
- Umeclidinium with vilanterol: Anoro Ellipta (US and Canada); indacaterol with glycopyrronium: Ultibro Breezhaler (Canada).
Tiotropium alone is sold as Spiriva HandiHaler capsules and Spiriva Respimat (US, UK and Canada) and as generic 18 mcg capsules (for example Lupin's in the US, Canada and Australia, and Apotex's in Canada). In the FDA database, the only formoterol-only products still marketed are nebuliser solutions (Perforomist and generics); the Foradil dry powder inhaler is listed as discontinued; in the UK, formoterol-only inhalers include Formoterol Easyhaler.
What exists for Duova itself is limited. India's drug controller list records the Rotacap approval (22 April 2004) among several tiotropium with formoterol entries, including a tiotropium 18 mcg with formoterol 12 mcg dry powder inhaler (22 November 2004) and the 9 mcg with 6 mcg metered dose inhaler (24 December 2004). The one published trial of Cipla's combination we found (Salvi 2014) used the pressurised inhaler, not the Rotacaps: 44 people with moderate to severe COPD took a single dose of tiotropium 18 mcg, or tiotropium 18 mcg with formoterol 12 mcg, on two separate days, and the combination gave a faster and larger rise in lung function over 24 hours than tiotropium alone. In a PubMed search on 21 October 2026 we found no published trial of the Rotacaps and no long-term trial of either Duova form. Long-term evidence for adding a LABA to tiotropium comes from other products: a Cochrane review of 10 trials (10,894 people; 4 trials used olodaterol, 3 indacaterol, 2 formoterol and 1 salmeterol) found small improvements in quality of life and lung function over tiotropium alone, and no significant difference in hospital admissions or deaths, though the authors note there may not have been enough data.
Compared with Spiriva, Stiolto and US generics
| Product (not the same as Duova) | What it is | FDA approved | US pharmacy cost (NADAC) | Per day at the label dose |
|---|---|---|---|---|
| Duova Rotacaps (ours) | Tiotropium 18 mcg with formoterol 12 mcg per capsule | No | $0.80 to $0.87 per capsule, our price before shipping | About $0.80 to $0.87 at one capsule once a day, or $1.60 to $1.73 at one capsule twice a day (our arithmetic) |
| Spiriva HandiHaler 18 mcg | Tiotropium dry powder capsule, 1 capsule once daily | Yes | $10.60313 to $11.62133 per capsule | $10.60 to $11.62 |
| Generic tiotropium 18 mcg capsule | Tiotropium dry powder capsule, 1 capsule once daily | Yes | $11.89635 per capsule | $11.90 |
| Stiolto Respimat | Tiotropium 2.5 mcg with olodaterol 2.5 mcg, 2 puffs once daily, 60 puffs per cartridge (at least 4 g) | Yes | $115.76814 per gram (about $463 a cartridge) | About $15.44 |
| Generic formoterol 20 mcg/2 mL nebuliser vial | Formoterol alone, 1 vial twice daily by nebuliser | Yes | $1.08163 to $1.39496 per mL | About $4.33 to $5.58 |
NADAC (National Average Drug Acquisition Cost) is what US pharmacies pay to buy a medicine, published by the US Medicaid programme; it is not the price a patient pays at the counter. Rows are from the NADAC file dated 21 October 2026, with an effective date of 21 October 2026 for every row shown. Cartridge and per day figures are our arithmetic from the per gram or per mL rates and the label fill and dose. In the US, generic tiotropium capsules cost pharmacies slightly more per capsule than Spiriva HandiHaler in this file.
These are different products, approved on their own trials, and Duova is not a generic of any of them. Our per day cost is far lower, but a lower price does not make an unapproved combination the same as a licensed one. If you are in the US, the UK, Canada or Australia and have a prescription, ask your doctor or pharmacist about the licensed options and your insurance or subsidised price first.
Duova Rotacaps, Duova Inhaler and Tiova
| Product | Contents | Per 1 capsule or 2 puffs | Device |
|---|---|---|---|
| Duova Rotacaps (this page) | Tiotropium 18 mcg with formoterol 12 mcg per capsule | Tiotropium 18 mcg with formoterol 12 mcg | Dry powder capsule for a Rotahaler |
| Duova Inhaler | Tiotropium 9 mcg with formoterol 6 mcg per puff, 200 puffs | Same numbers in 2 puffs | Pressurised metered dose inhaler |
| Tiova Rotacaps | Tiotropium 18 mcg per capsule, no formoterol | Tiotropium 18 mcg | Dry powder capsule |
| Tiova Inhaler | Tiotropium 9 mcg per puff, no formoterol | Tiotropium 18 mcg | Pressurised metered dose inhaler |
The same number of micrograms in different devices does not mean the same dose reaches the lungs. Under standard laboratory testing, a Spiriva HandiHaler 18 mcg capsule delivers a mean of 10.4 mcg of tiotropium from the device, and the US label says the amount delivered to the lungs varies with how hard the patient breathes in and with how long the capsule has been outside its blister (US label 11). The Indian listings do not say how much of Duova's 18 mcg leaves a Rotahaler. They also disagree on what the 18 mcg counts: India's approval record (CDSCO item 447) and the PharmEasy listing say tiotropium bromide 18 mcg, while Apollo says tiotropium 18 mcg. Spiriva's 18 mcg is tiotropium itself, equal to 22.5 mcg of tiotropium bromide monohydrate. If Duova's figure is tiotropium bromide, a capsule holds about 15 mcg of tiotropium (our arithmetic). Moving between these products, or from them to a licensed inhaler, is a decision for your doctor.
How often to use it: the labels disagree
We have not seen Cipla's prescribing information for Duova Rotacaps, so we cannot quote its labelled schedule. The Apollo listing says it is recommended twice a day or as advised by your doctor; the PharmEasy listing gives no frequency. Each capsule is labelled tiotropium 18 mcg, the same figure as a Spiriva HandiHaler capsule's once daily dose (whether Duova's 18 mcg is tiotropium or tiotropium bromide is not confirmed; see above). The single-ingredient labels point in different directions:
- Tiotropium: once daily. The US Spiriva HandiHaler label says do not take more than one dose in 24 hours, and the UK Spiriva label says tiotropium "should not be used more frequently than once daily".
- Formoterol: twice daily, morning and evening. The UK Formoterol Easyhaler label gives 12 mcg twice daily for COPD, with a maximum of 24 mcg a day, and says its effect lasts about 12 hours. The US Perforomist label gives one 20 mcg nebuliser vial twice daily, with no more than 40 mcg a day.
Because both medicines are in one capsule, one capsule once a day gives formoterol once a day, and one capsule twice a day gives 36 mcg of the labelled tiotropium figure a day (about 30 mcg of tiotropium if the figure is tiotropium bromide), well above the once daily 18 mcg in the single-ingredient tiotropium labels (our arithmetic). Neither schedule matches both single-ingredient labels (our reading of the labels; they are for other devices). Follow the schedule your doctor sets, do not add extra capsules, and do not use another LAMA or LABA inhaler at the same time unless your doctor has planned it.
How to use Duova Rotacaps
These steps follow Cipla's Rotahaler instructions on CiplaMed. Read the leaflet in your pack and the leaflet with your device first, and follow them where they differ from ours.
- Never swallow a capsule. The US Spiriva HandiHaler label says "Do not swallow SPIRIVA capsules, as the intended effects on the lungs will not be obtained", and the PharmEasy listing says "Never swallow a rotacap capsule." If you swallow one by mistake, the US label says acute intoxication from swallowing a capsule is unlikely because tiotropium is not well absorbed into the body; ask your doctor or pharmacist before your next dose rather than taking an extra capsule (our advice).
- Hold the Rotahaler upright and line up its two halves so the fin is not directly below the rotacap hole.
- Take one capsule out of its container only when you are ready to use it, and put it into the rotacap hole with the transparent end facing down. Close the container tightly straight away.
- Hold the mouthpiece firmly with one hand and rotate the base.
- Breathe out fully, away from the device (our addition). Put the mouthpiece between your teeth, close your lips tightly around it, tilt your head slightly back and breathe in through your mouth quickly and deeply.
- Hold your breath for 10 seconds, or as long as is comfortable, then breathe out normally. If some powder remains, breathe in from the device again. Then open the Rotahaler and throw away the empty capsule shell.
- Do not let the powder get into your eyes. The US Spiriva HandiHaler patient information says vision may get blurry and the pupil may get larger if it does, and the UK Spiriva label (4.4) warns that tiotropium in the eyes may bring on or worsen narrow-angle glaucoma.
- Keep the device clean and dry. Cipla's instructions say to separate the two halves, rinse them in clean running water, shake off the water and leave them to air dry; never use the Rotahaler while it is wet, and replace it after up to 6 months of daily use.
- Use it at the same times every day, even when you feel well. Keep a fast-acting reliever, such as salbutamol or levosalbutamol, for sudden symptoms. The US Stiolto label says that when prescribing Stiolto, the healthcare provider should also prescribe an inhaled short-acting reliever.
- If you miss a dose, take it when you remember unless the next dose is nearly due, and do not take a double dose (PharmEasy listing).
- Dry mouth is common with tiotropium, and the UK label says long-term dry mouth may be linked with tooth decay, so keep up dental care.
The container in our product photo says "For use with rotahaler". Cipla also makes the Revolizer, whose instructions also tell you to take a rotacap from its bottle, but the Duova container names the Rotahaler, so ask your pharmacist before using another device. Do not put Duova capsules in a HandiHaler or any other brand's device: the US label says the HandiHaler is only intended for Spiriva capsules.
Keeping the capsules dry
Dry powder capsules are sensitive to moisture. The US Spiriva HandiHaler label says the capsules "should not be exposed to extreme temperature or moisture", should be removed from the blister only immediately before use, and that capsules exposed to air and not used straight away should be thrown away. The UK Spiriva label says to use the capsules within 9 days of first opening a blister and not to store them above 25 C. Duova Rotacaps come in a container rather than single blisters in our product photo; Cipla's Rotahaler instructions say to keep the rotacap bottle tightly closed to avoid exposure to moisture and to insert a rotacap just before use. The container label in our photo says to keep the container tightly closed and protect it from heat and moisture; we cannot read its storage temperature in the photo. The Apollo listing gives 20 to 25 C, and the PharmEasy listing says to protect the capsules from heat and moisture (it mentions a blister, which does not match the container in our photo). Follow the carton. Never keep a capsule in the Rotahaler between doses, and do not store the container in a bathroom or other damp place (our advice, in line with the US HandiHaler label's warnings against storing capsules in the device and against moisture).
Not for asthma, and not a reliever
Duova contains no inhaled steroid. The US formoterol (Perforomist) and Stiolto labels both say: "Use of a LABA ... without an inhaled corticosteroid is contraindicated in patients with asthma." They explain that LABA used alone for asthma "is associated with an increased risk of asthma-related death", and that this is considered a class effect. The UK formoterol label says it "should not be used (and is not sufficient) as the first treatment for asthma" and that people with asthma who need a LABA should also receive an inhaled corticosteroid. India's approval for Duova Rotacaps is for COPD; the Apollo listing also mentions asthma, but that is not the approved use. In our view, if you have asthma, or asthma and COPD together, do not use Duova unless a specialist has added it to a plan that includes an inhaled steroid.
It is also not a rescue treatment. The US Spiriva and Stiolto labels say these maintenance inhalers should not be used for the relief of acute symptoms, and that Stiolto "should not be initiated in patients with acutely deteriorating COPD, which may be a life-threatening condition". Needing your reliever more than usual is, in the Stiolto label's words, "a signal of deteriorating disease for which prompt medical attention is indicated". Do not take extra Duova capsules to make up for it.
Kidney, liver and older age
- Kidney impairment: tiotropium is mostly cleared by the kidneys. The US labels say people with a creatinine clearance below 60 mL/min should be monitored closely for anticholinergic side effects. The UK label says that at 50 mL/min or less, tiotropium should be used only if the expected benefit outweighs the potential risk.
- Liver impairment: the US tiotropium labels need no dose change. The UK formoterol label says formoterol is mainly removed by the liver, so higher exposure can be expected in severe cirrhosis.
- Older people: the US tiotropium labels need no dose change for age.
Side effects
We found no published side effect table for Duova itself, so here are the tables for each medicine on its own. They come from separate trials of different devices and doses; do not add them together.
| Reaction | Tiotropium 18 mcg once daily (550 people) | Placebo (371 people) |
|---|---|---|
| Upper respiratory tract infection | 41% | 37% |
| Dry mouth | 16% | 3% |
| Sinusitis | 11% | 9% |
| Sore throat (pharyngitis) | 9% | 7% |
| Chest pain (non-specific) | 7% | 5% |
| Urinary tract infection | 7% | 5% |
| Constipation | 4% | 2% |
| Rash | 4% | 2% |
Selected rows from Table 1 of the US Spiriva HandiHaler label (1 year placebo-controlled COPD trials of the 18 mcg capsule). The label says dry mouth was usually mild and often resolved during continued treatment, and lists constipation, fast heartbeat, blurred vision, new or worse glaucoma, painful urination and urinary retention as reactions consistent with its anticholinergic effect.
| Reaction | Formoterol 20 mcg twice daily, nebulised (123 people) | Placebo (114 people) |
|---|---|---|
| Diarrhoea | 4.9% | 3.5% |
| Nausea | 4.9% | 2.6% |
| Nose and throat infection | 3.3% | 1.8% |
| Dry mouth | 3.3% | 1.8% |
| Vomiting | 2.4% | 1.8% |
| Dizziness | 2.4% | 0.9% |
| Insomnia | 2.4% | 0% |
Table 1 of the US Perforomist label (12 week COPD trial). For a LAMA plus LABA in one inhaler, the US Stiolto label's two 52 week trials found nasopharyngitis in 12.4%, cough in 3.9% and back pain in 3.6% of people on the combination, against 11.7%, 4.4% and 1.8% on tiotropium alone and 12.6%, 3.0% and 3.4% on olodaterol alone (there was no placebo arm). Beta2 agonists such as formoterol can also cause tremor and palpitations, raise blood sugar and lower potassium.
When to get urgent help
- Breathing that gets worse quickly, or a reliever that does not relieve it: call emergency services now (911 in the US and Canada, 999 in the UK, 000 in Australia) or go to the nearest emergency department. The US Stiolto patient information says to get emergency medical care if "your breathing problems worsen quickly" or "you use your rescue inhaler medicine, but it does not relieve your breathing problems".
- Wheezing or breathlessness that gets worse straight after a dose (paradoxical bronchospasm): use your reliever, stop Duova and get medical help now. The US Spiriva HandiHaler label says to treat it immediately with a short-acting reliever such as albuterol (salbutamol), and the US Stiolto label says it may be life-threatening.
- Swelling of the face, lips, tongue or throat, trouble breathing or swallowing, hives, rash or itching: signs of an allergic reaction. Stop Duova and get emergency help right away (US Stiolto patient information).
- Eye pain or discomfort, blurred vision, halos or coloured images around lights, with red eyes: possible acute narrow-angle glaucoma. The US labels say to consult a physician immediately; the UK label says stop tiotropium and see a specialist immediately. In our view this needs emergency eye care the same day.
- Difficulty passing urine, painful urination, or a weak stream or drips: the US Stiolto patient information says to call your healthcare provider right away. Being unable to pass urine at all needs emergency care (our advice).
- Chest pain, a very fast or irregular heartbeat, fainting or a seizure.
- Taking far more capsules than prescribed. The US Spiriva HandiHaler label describes a woman who inhaled 30 capsules over 2.5 days and was admitted to hospital with altered mental status, tremors, abdominal pain and severe constipation; she recovered. The US Stiolto label says clinically significant cardiovascular effects and fatalities have been reported with excessive use of inhaled sympathomimetic drugs. For poisoning advice, call 1-800-222-1222 in the US or 13 11 26 in Australia.
Tell the emergency staff which inhalers you use, how many capsules you took and when.
Who should not use Duova Rotacaps
Never use it (contraindications in the single-ingredient labels):
- if you are allergic to tiotropium, ipratropium or any component of the product (US Spiriva labels); the UK Spiriva label adds atropine and its derivatives, such as ipratropium or oxitropium, and the excipient
- if you are allergic to formoterol (UK formoterol label)
- for asthma without an inhaled corticosteroid (US Perforomist and Stiolto labels: contraindicated)
Use with caution, and talk to a doctor first:
- Milk protein allergy or rare sugar disorders. Spiriva capsules contain lactose, which the US and UK labels say may contain milk proteins; the US patient information asks people with a severe allergy to milk proteins to tell their doctor, and the UK label says people with rare hereditary galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption should not take Spiriva. We cannot read the excipient line on the Duova container in our photo, but the PharmEasy listing says not to use Duova Rotacaps if you are allergic to milk proteins, and the Apollo listing gives the same warning.
- Narrow-angle glaucoma, an enlarged prostate, bladder-neck obstruction or trouble passing urine (US and UK tiotropium labels).
- Heart disease: the US Stiolto label advises caution with coronary insufficiency, arrhythmias, hypertrophic obstructive cardiomyopathy and high blood pressure, and notes that beta agonists can prolong the QTc interval. The UK Spiriva label advises caution after a heart attack in the last 6 months, an unstable or life-threatening arrhythmia, or a hospital stay for severe heart failure in the past year, because these people were excluded from the trials.
- Seizure disorders, an overactive thyroid, or being unusually sensitive to sympathomimetic medicines (US Stiolto label 5.7); diabetes (the UK formoterol label recommends extra blood glucose checks at first); low potassium (US Stiolto label 5.11).
- Kidney impairment (see above).
- Medicines: other anticholinergic inhalers or medicines, such as ipratropium (the US Stiolto label says avoid using them together); other medicines containing a LABA (the US Stiolto label says not to use them together, as an overdose may result); beta blockers (the US Stiolto label says people with COPD "should not normally be treated with beta-blockers"); MAO inhibitors, tricyclic antidepressants and other drugs that prolong the QTc interval ("extreme caution"); and diuretics, steroids or theophylline, which can add to low potassium.
- Pregnancy: the US Stiolto label says use "only if the potential benefit justifies the potential risk to the fetus", and the UK Spiriva label says "it is preferable to avoid the use of Spiriva during pregnancy". Because beta agonists may interfere with contractions, the US Stiolto label restricts use during labour to people "in whom the benefits clearly outweigh the risks".
- Breastfeeding: the US Stiolto label says there are no data on tiotropium in human milk. The UK Spiriva label says use "is not recommended during breast-feeding" and that the decision should weigh the benefit of breastfeeding against the benefit of treatment.
- Children and young people: COPD does not normally occur in children (US Stiolto label), and the UK Spiriva label gives no relevant use below 18. Duova Rotacaps are not a children's medicine.
Prescription and legal status
Tiotropium and formoterol medicines are prescription-only in the US, the UK (Spiriva is a prescription only medicine on the emc), Canada (Health Canada lists Spiriva, Inspiolto and Duaklir as prescription) and Australia (Spiolto Respimat is Schedule 4). In India, the container in our product photo is marked "Rx", the PharmEasy listing requires a prescription, and Apollo marks it as a prescription drug. Duova Rotacaps are not approved in the US, UK, Canada or Australia; no tiotropium with formoterol product is approved by the FDA or Health Canada, and we found none authorised in the UK or Australia. In the US the FDA says personal importation of unapproved medicines is illegal in most circumstances. COPD needs regular review by a doctor or nurse, including spirometry, an inhaler technique check and a plan for flare-ups. Check the rules where you live.
Buying genuine Duova Rotacaps
The MHRA warns: "Any medicine not authorised for sale in the UK can be unsafe or ineffective and there is no way of knowing what is in them or the negative health effects they can have." It also advises: "Only use UK-registered pharmacies, including online pharmacies displaying the official green cross logo." That warning covers Duova Rotacaps, which are not authorised in the UK. When your order arrives, check that the carton and container name Cipla, tiotropium and formoterol, say 30 capsules, are sealed, and show a batch number and an expiry date. These checks cannot prove a pack is genuine, because counterfeiters copy packaging. If the capsules do not seem to work the way your previous supply did, see a doctor rather than taking extra capsules. If a batch causes unusual symptoms, seek medical advice and report it to your medicines regulator (the MHRA Yellow Card scheme in the UK, FDA MedWatch in the US, the TGA in Australia or Health Canada) as well as to us.
Delivery
We ship Duova Rotacaps to the US, UK, Australia and Canada in plain packaging with tracking. Standard delivery takes 7 to 14 business days to most countries, so order well before your current container runs out. Shipping costs a flat $25 on orders under $149 and is free from $149. See our shipping page and refund policy.
Related guides
- Rotacaps vs inhaler vs respules: which device gets the dose into your lungs
- Tiotropium inhaler guide: why 18 mcg and 5 mcg are the same dose, and who benefits
- Breztri vs Trelegy: triple inhalers for COPD and asthma compared
- Budesonide with formoterol inhalers: doses, MART and the trials
Other COPD products we stock: Triohale Rotacaps (tiotropium, formoterol and ciclesonide), Foracort 200 Inhaler (budesonide with formoterol) and Asthalin Rotacaps (salbutamol reliever capsules).
Sources
- Spiriva HandiHaler (tiotropium bromide inhalation powder), Boehringer Ingelheim, US prescribing information, patient information and Instructions for Use, DailyMed setid 820839ef-e53d-47e8-a3b9-d911ff92e6a9, version 28, November 2025, sections 1 to 6, 8, 10, 11, 12.3, 16 and 17. DailyMed
- Spiriva Respimat (tiotropium bromide inhalation spray), US prescribing information, DailyMed setid 7b656b14-fcaa-2741-f6f0-e0be48971c02, version 16, August 2026, sections 1 to 5. DailyMed
- Stiolto Respimat (tiotropium bromide and olodaterol inhalation spray), US prescribing information and patient information, DailyMed setid 01e15aee-40e0-23f3-537f-c96dd63e2cb1, version 16, July 2025, sections 1 to 8, 10, 16 and 17. DailyMed
- Perforomist (formoterol fumarate inhalation solution), Viatris, US prescribing information, DailyMed setid fb2fe258-fe2e-47f6-8adf-ca75bf6f90af, version 22, February 2025, sections 1, 2, 4, 5, 6 and 10. DailyMed
- Spiriva 18 microgram inhalation powder, hard capsule. UK summary of product characteristics, revised March 2023, sections 2, 4.1 to 4.8 and 6. emc
- Formoterol Easyhaler 12 micrograms per dose inhalation powder. UK summary of product characteristics, revised 2 February 2022, sections 4.1 to 4.4 and 4.8. emc
- Central Drugs Standard Control Organisation. Fixed dose combinations approved by DCG(I) since 1961 to 31st December 2019, items 447 (tiotropium bromide 18 mcg with formoterol 12 mcg Rotacap, COPD, 22.04.2004), 452 (dry powder inhaler, 22.11.2004) and 454 (metered dose inhaler, 24.12.2004). CDSCO
- US FDA drug approvals (openFDA drugsfda), Health Canada Drug Product Database and the UK emc, searched for tiotropium, formoterol and other LAMA and LABA ingredients on 21 October 2026. openFDA, Health Canada DPD
- healthdirect Australia. Spiolto Respimat, Schedule 4 prescription only medicine. healthdirect
- Cipla (CiplaMed). How to use the Rotahaler, patient education page, 14 October 2016, and How to use the Revolizer. Rotahaler, Revolizer
- Salvi S, et al. Bronchodilator efficacy of tiotropium-formoterol via single pressurized meter dose inhaler (pMDI) versus tiotropium alone in COPD. Pulm Pharmacol Ther 2014. PMID 23752057.
- Farne HA, Cates CJ. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2015. PMID 26490945.
- Centers for Medicare and Medicaid Services. National Average Drug Acquisition Cost (NADAC), 2026 file dated 21 October 2026: Spiriva HandiHaler, Stiolto Respimat, tiotropium 18 mcg capsule and formoterol 20 mcg/2 mL rows. data.medicaid.gov
- PharmEasy and Apollo Pharmacy. Duova Rotacaps (Cipla) product listings, accessed 21 October 2026. PharmEasy, Apollo
- MHRA. 20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys, 13 February 2026. GOV.UK
- US Food and Drug Administration. Personal Importation. FDA
This page is for information and is not medical advice. Tiotropium and formoterol are prescription medicines; your doctor should set your dose and your COPD action plan.
Frequently asked questions
What is Duova Rotacaps?
Duova Rotacaps are Cipla's dry powder capsules for COPD, used with a Rotahaler device. Each capsule contains tiotropium 18 mcg, a long-acting antimuscarinic bronchodilator, and formoterol 12 mcg, a long-acting beta2 agonist bronchodilator. India's drug controller approved this Rotacap for COPD in April 2004. No tiotropium with formoterol product is approved by the FDA or Health Canada, and we found none on the UK emc or registered with the TGA.
Is Duova Rotacaps the same as Spiriva or Stiolto?
No. Spiriva HandiHaler capsules contain tiotropium alone, and Stiolto Respimat pairs tiotropium with a different LABA, olodaterol. Duova Rotacaps pair tiotropium with formoterol in one capsule, a combination that is not licensed in the US or Canada, and that we found licensed in neither the UK nor Australia. The one published study of Cipla's tiotropium with formoterol we found (Salvi 2014, 44 people, single dose) used the pressurised inhaler, not the Rotacaps, and we have seen no data comparing Duova Rotacaps with Spiriva or Stiolto.
What does Duova Rotacaps cost?
As of October 2026 it costs $26 for 1 container of 30 capsules ($0.87 a capsule), $50 for 2 containers ($0.83) and $72 for 3 containers ($0.80), before shipping. All packs are under $149, so each order carries $25 shipping: $1.70, $1.25 or $1.08 a capsule with shipping. The pack selector shows the current price. By our arithmetic a container lasts 30 days at one capsule once a day, or 15 days at one capsule twice a day.
How do I use Duova Rotacaps?
Never swallow a capsule: it is for inhalation only. Take one capsule out of its container just before use, close the container tightly, and put the capsule into the Rotahaler with the transparent end facing down. Rotate the base, breathe out fully, then breathe in quickly and deeply through the mouthpiece and hold your breath for about 10 seconds. If powder remains, breathe in again, then throw the empty shell away. These steps follow Cipla's Rotahaler instructions; follow the leaflet in your pack where it differs.
How many capsules a day should I take?
Your doctor should set this. We have not seen Cipla's prescribing information. The Apollo listing says twice a day. The single-ingredient labels differ: tiotropium is used once daily and not more than once in 24 hours, while formoterol is used twice daily, about 12 hours apart. Each Duova capsule is labelled tiotropium 18 mcg, the same figure as the once daily Spiriva capsule, so one capsule twice a day gives well above the labelled once daily tiotropium dose. Do not add extra capsules on your own.
Can I use Duova Rotacaps for asthma?
Not on their own. Duova contains no inhaled steroid, and the US formoterol and Stiolto labels say a LABA without an inhaled corticosteroid is contraindicated in patients with asthma, because LABA used alone for asthma is associated with an increased risk of asthma-related death. The UK formoterol label says it "should not be used (and is not sufficient) as the first treatment for asthma". India's approval for Duova Rotacaps is for COPD.
Can I use Duova Rotacaps as a rescue treatment?
No. The US tiotropium and Stiolto labels say these maintenance inhalers should not be used to relieve acute symptoms. Use a short-acting reliever such as salbutamol for sudden breathlessness. If breathing worsens quickly or your reliever does not help, call emergency services: 911 in the US and Canada, 999 in the UK or 000 in Australia.
What are the side effects of Duova Rotacaps?
We found no published side effect table for Duova itself. In the US Spiriva HandiHaler trials of the 18 mcg capsule, dry mouth affected 16% on tiotropium against 3% on placebo, and constipation, urinary tract infection and sinusitis were also more common. In a 12 week US trial of nebulised formoterol, nausea, diarrhoea, dizziness and insomnia were slightly more common than on placebo. Tiotropium can worsen narrow-angle glaucoma and urinary retention, and formoterol can raise heart rate, raise blood sugar and lower potassium.
Who should not use Duova Rotacaps?
Do not use it if you are allergic to tiotropium, ipratropium, atropine derivatives, formoterol or any ingredient, or for asthma without an inhaled steroid. The PharmEasy and Apollo listings also warn against it with a milk protein allergy. Talk to a doctor first if you have narrow-angle glaucoma, an enlarged prostate or trouble passing urine, heart disease or a recent heart attack, seizures, an overactive thyroid, diabetes, low potassium or kidney impairment, or if you take other anticholinergic or LABA inhalers, beta blockers, MAO inhibitors or tricyclic antidepressants. It is not for children.
Do I need a prescription for Duova Rotacaps?
Tiotropium and formoterol medicines are prescription-only in the US, UK, Canada and Australia, and in India the container in our product photo is marked Rx and the listings we checked treat it as a prescription medicine. No regulator in those four countries has approved Duova Rotacaps, and in the US the FDA says personal importation of unapproved medicines is illegal in most circumstances. COPD needs regular review by a doctor or nurse.
How long does delivery take?
We ship to the US, UK, Australia and Canada in plain packaging with tracking. Standard delivery takes 7 to 14 business days, so order well before your current container runs out. Shipping is a flat $25 on orders under $149 and free from $149.
Medical References
Sources: U.S. National Library of Medicine (DailyMed, PubMed), openFDA
Related articles
Customer Reviews
No reviews yet. Bought Duova Rotacaps? Tell other buyers how it went.







